BlackRock Japan’s vTv Therapeutics VTVT Stock Holding History

BlackRock Japan’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-19	Closed	-$4K	–	1426
2016 Q2	$4K	Buy	19 +12	+171%	+$2.76K	﹤0.01%	1362
2016 Q1	$1K	Sell	7 -13	-65%	-$3.24K	﹤0.01%	1422
2015 Q4	$5K	Buy	20 +15	+300%	+$4.21K	﹤0.01%	1327
2015 Q3	$1K	Buy	+5	New	+$1.74K	﹤0.01%	1254

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

PSC

Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock Japan's VTVT Position: Q3 2016 in Review

BlackRock Japan sold out of vTv Therapeutics (VTVT) in Q3 2016, closing a stake of 19 shares — an estimated $4K sold.

BlackRock Japan first reported a position in VTVT in Q3 2015 and held it in 4 quarters. The position peaked at $5K in Q4 2015. 36 funds tracked by Wall St. Rank hold VTVT as of Q3 2016.

BlackRock Japan reported no remaining vTv Therapeutics position as of Q3 2016 after selling out during the quarter.
BlackRock Japan sold 19 vTv Therapeutics shares in Q3 2016, an estimated $4K.
BlackRock Japan first reported a position in vTv Therapeutics in Q3 2015 and held it in 4 quarters.
BlackRock Japan's vTv Therapeutics position peaked at $5K in Q4 2015.
36 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.